This is the authors' abstract. We don't add key points for this paper.
Disclosure of HIV status pose a great challenge in many societies due to associated stigma. We prospectively investigated whether or not HIV-status disclosure before commencement of antiretroviral therapy (ART) has influence on adherence, immunological response and viral load suppression (VLS) in HIV-infected patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Deus Buma (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: